Medicinal Value Of Psydrax Umbellata: Therapeutic Innovation And Biodiversity Conservation

Abstract

Current research interest in the Rubiaceae family plants, remarks the pharmacological potential of underutilized species, including Psydrax, known for antioxidant, anti-inflammatory, and antimicrobial properties. In spite of 37 Psydrax species hold ethnomedicinal value for treating ailments such as diabetes, gastrointestinal disorders, and infections. Research on specific species like Psydrax umbellata known to be still untouched part. Despite its traditional medicinal uses, studies on P. umbellata's pharmacological and chemical properties are limited. Which provides scope for novel drug exploration and biodiversity conservation. This species, like other Psydrax members, is rich in bioactive compounds such as alkaloids, flavonoids, saponins, and tannins, which contribute to its therapeutic potential. However, comprehensive investigations into its chemical composition, pharmacological effects, and safety are needed to validate its medicinal claims. This review envisages the significance of advancing research on P. umbellata, with implications for biodiversity preservation and the development of new pharmacological agents.